MC10 Completes Series B Fundraising With Addition of Windham Venture Partners
(firmenpresse) - CAMBRIDGE, MA -- (Marketwire) -- 09/07/11 -- MC10 announced today the completion of their Series B fundraising with the addition of $2.25M from Windham Venture Partners, bringing the round's total to $14.75M. Windham provides experience and expertise that will boost MC10's commercialization efforts across medical device and healthcare applications.
Windham has deep connections across the health care continuum, both through established strategics and earlier stage portfolio companies. The firm appreciates the benefits of MC10's strategy to commercialize health and wellness products for consumers first.
"MC10 represents a game-changing technology for medical devices and health care electronics," said Adam Fine, Managing Director, Windham Venture Partners. "We are pleased to provide both capital and expertise to accelerate their products and partnerships in life science applications."
MC10's ability to create bendable, stretchable systems out of otherwise rigid high performance electronics has immediate benefits for health and wellness products. For example, MC10 is working on 'electronic skin,' which can measure everything from heart rate to activity level to hydration, all in a thin, sticker-like package. This has enormous potential in the health, wellness, and health care markets.
The company's active partnerships, collaborations, and funding sources, including Massachusetts General Hospital, the US Navy, and Reebok, demonstrate the broad impact of MC10's platform.
For MC10, Windham's support and involvement represents an ideal addition to the existing team. "Windham complements the skills and interests of our other venture investors," said MC10's CEO David Icke. "They bring a driven, entrepreneurial approach along with a deep knowledge and far-reaching experience that will help us build our life science electronics business."
MC10 takes electronics 'out of the box' to create thin, conformal systems that are able to move with the natural world. The company combines breakthrough technology with innovative engineering to develop exciting new consumer, medical, and industrial products. MC10 is headquartered in Cambridge, MA. Visit MC10 online at .
Windham Venture Partners is a New York-based venture investment firm focusing on breakthrough life sciences technologies, primarily medical devices and diagnostics. The firm has deep experience and expertise in life sciences. The firm invests in all stages, from creating companies to investing in later stage opportunities. The firm focuses on commercializing cutting edge technologies to address significant unmet medical needs. Additional information is available online at
Gilman Callsen
MC10
(617) 234-4448
Doug Arbesfeld
SmithSolve for Windham Venture Partners
(908) 347-9877
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 07.09.2011 - 13:00 Uhr
Sprache: Deutsch
News-ID 62941
Anzahl Zeichen: 0
contact information:
Town:
CAMBRIDGE, MA
Kategorie:
Venture Capital
Diese Pressemitteilung wurde bisher 186 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"MC10 Completes Series B Fundraising With Addition of Windham Venture Partners"
steht unter der journalistisch-redaktionellen Verantwortung von
Windham Venture Partners (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
